Robin Carr

Company: Myricx Bio

Job title: Chief Executive Officer

Bio:

Robin joined Myricx in Nov 2019 as chief development officer and became CEO in August 2022. Prior to Myricx, Robin was at GSK where he held several research Exec roles (2007-2019). Robin served as a member of GSK’s Discovery Investment Board, Technology Investment Board and co-chaired the target selection committee.

Prior to GSK, Robin was VP of drug discovery at Astex Therapeutics (1999-2007), with responsibility for internal and partnered drug discovery programs.

Seminars:

Novel & Dual Payloads: Assessing Linker Conjugation Technologies That Encourage Flexibility in Payloads 4:00 pm

Evaluating the right ratios, the advantages of releasing drugs in specific ratios, and which combination of drugs make sense when considering dual payloads Discussing how novel payloads hold promise to overcome drug resistance Advancing cytoxic or immune-stimulating payloads with novel MoAsRead more

day: Day One P3